financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of First Horizon Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of First Horizon Corporation
Jul 16, 2025 8:48 AM

11:25 AM EDT, 07/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target price by $6 to $28, applying a forward P/E of 14.3x our 2026 EPS estimate, a premium to the peer average of 12.7x, as the bank benefits from superior credit quality. We raise our 2025 EPS estimate by $0.10 to $1.82 and increase 2026's by $0.12 to $1.96. FHN maintains a strong financial position despite broader economic uncertainties, as tariff-related concerns have not yet affected the bank's loan demand or credit quality. The bank's CET1 ratio of 11.0%, well above historical norms, provides significant strategic flexibility, allowing FHN to aggressively pursue loan growth opportunities within its attractive Southeast branch network or accelerate share buybacks. Recent stress test results, indicating less restrictive capital requirements for the industry, create additional regulatory tailwinds that support a positive outlook for the bank. Furthermore, management's updated guidance demonstrates disciplined cost control as expense expectations were reduced to 0%-2% from 2%-4%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Advanced Micro Devices, Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Advanced Micro Devices, Inc.
Oct 6, 2025
09:45 AM EDT, 10/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $250 from $200 on a higher P/E of 32.8x our 2027 EPS view, above peers and near historical, after AMD announced a partnership with...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Agilent Technologies, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Agilent Technologies, Inc.
Oct 5, 2025
12:45 AM EDT, 10/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $160 (from $143), 26.2x our FY 26 (Oct.) EPS view, in line with A's five-year forward P/E average. We retain our FY 25 EPS...
Research Alert: CFRA Upgrades To Buy From Hold Opinion On Shares Of Spotify Technology S.a.
Research Alert: CFRA Upgrades To Buy From Hold Opinion On Shares Of Spotify Technology S.a.
Sep 30, 2025
02:40 PM EDT, 09/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We see an enhanced buying opportunity with the share price down today on news of leadership changes at the company. We keep our 12-month target price at $790 per share...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pfizer Inc. After Key Deal
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pfizer Inc. After Key Deal
Sep 30, 2025
03:50 PM EDT, 09/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Shares of Pfizer ( PFE ) are up more than 5% D/D after the announced agreement today with the U.S. government to lower drug prices in the U.S. This is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved